ClinicalTrials.gg
RecruitingNCT06267638Updated Mar 12, 2024

Comparison of Postoperative Pain Score Between Perioperative Intravenous Ketamine and Placebo in Patients Undergoing Unilateral Total Knee Arthroplasty Under General Anesthesia

A Phase 4 interventional study of Ketamine group and Placebo group in Knee Osteoarthritis, sponsored by Ministry of Health, Thailand. Recruiting at 1 site in Thailand. Open to participants aged 18 Years to 100 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-03-12.

Sponsored by Ministry of Health, Thailand · Phase 4, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as recruiting.
  • Started Jan 2024; still recruiting 2 years 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 4
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 100 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 44 studies in Osteoarthritis, Knee with a site in Thailand — 7 open to participants now, 9 under way, 2 of them phase 3. Osteoarthritis, Knee · Thailand.

Planned enrollment
17th of 40
100 · median 97
Started
2024
with 4 others
Phase 4
9 of 44
2 open now
Registered
36th of 44
by date
Lead sponsor
1 of 44
Ministry of Health, Thailand

Among the 44 studies in Osteoarthritis, Knee with a site in Thailand, this one is the 17th largest by planned enrollment of the 40 interventional ones that give a count, is one of 5 that started in 2024, is one of 9 in phase 4, and was the 36th registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

7 of the 44 studies in Osteoarthritis, Knee with a site in Thailand are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in Thailand have not opened yet or have stopped. Only those recruiting at a site in Thailand →

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 18 Years to 100 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 44 studies in Osteoarthritis, Knee with a site in Thailand, or all of them as a file.
02

Study summary

The goal of this clinical trial is to compare postoperative pain score between perioperative intravenous ketamine and placebo in patients undergoing unilateral total knee arthroplasty under general anesthesia. The main question[s] it aims to answer are:

  • Can perioperative intravenous ketamine reduce postoperative pain score during rest and movement at 0, 2, 4, 8, 12, 18, 24 hours better than no administration of Ketamine in patients undergoing Unilateral total knee arthroplasty under general anesthesia?
  • Can perioperative intravenous ketamine reduce morphine consumption in postoperative 24 hours, length of hospital stay, first time to receive opioid and side effect or complication from ketamine and opioid better than no administration of Ketamine in patients undergoing Unilateral total knee arthroplasty under general anesthesia? Participants will receive intravenous ketamine intraoperative TKA and comparison group will receive placebo that is normal saline. Researchers will compare perioperative intravenous ketamine and placebo to see postoperative pain score, morphine consumption in postoperative 24 hours, length of hospital stay, first time to receive opioid and side effect or complication from ketamine and opioid.
03

Conditions studied

  • Knee Osteoarthritis

Keywords

  • ketamine
  • total knee arthroplasty
  • general anesthesia
  • Total Knee Arthropathy
04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. A patient undergo unilateral total knee arthroplasty under General anesthesia at Chomthong Hospital Chiang Mai During 2024 to December 2025
  2. Age is more than 18 years old
  3. ASA () status are I,I,III
  4. A patient can cooperate in research

Exclusion criteria

Exclusion Criteria:

  • Patients allergic to local anesthetic agent
  • Patient who has to use ketamine
  • Patients has coagulopathy.
  • Injection site is infected.
  • Patients with chronic pain received painkillers for more than 3 months.
  • The patient has a history of opioid use.
  • The patient has a history of alcohol dependence.
  • Patients allergic to fentanyl or morphine.
  • Patient who has unstable cardiovascular disease
  • Patient who has increase intracranial pressure and high ocular pressure
  • Pregnancy
  • The patient who has communication problems cannot describe the level of pain
  • The patient refused to participate in the study.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    ketamine group

    Participant will receive intraoperative ketamine during total knee arthroplasty by Ketamine 0.5mg /kg loading then 0.25 mg/kg/hours until end of surgery

    Drug: Ketamine group

  • Placebo comparator
    Placebo group

    Participant will receive intraoperative normal saline during total knee arthroplasty

    Drug: Placebo group

Interventions

  • DrugKetamineStudies of KetamineKetamine pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    Participants will receive intraoperative ketamine during total knee arthroplasty

  • DrugPlacebo group

    Participants will receive intraoperative normal saline during total knee arthroplasty

06

What researchers measure

Primary outcomes

  1. Postoperative pain score at rest and movement

    pain score at rest and movement by numeric rating scale 0-10

    Time frame: post operative time at 0 ,2 ,4 ,8 ,12 ,18 ,24 hours

Secondary outcomes

  1. First time to receive intravenous analgesic drug

    First time to receive intravenous analgesic drug after operation was finished

    Time frame: First time to receive intravenous analgesic drug ( From finished anesthetic time until First time to receive intravenous analgesic drug(minute)

  2. Morphine consumption

    Post operative morphine consumption or morphine equivalent (milligram)

    Time frame: post operative time at 0 ,2 ,4 ,8 ,12 ,18 ,24 hours

  3. Length of hospital stay

    Length of hospital stay : When participant admit to discharge

    Time frame: Time that patient was admited to hospital until patient was discharge from hospital.

  4. side effect and complication from ketamine and opioid

    Number of Participants with side effect form Ketamine and opioid: Hallucination, Nightmare, Arrythmia , Nausea vomiting respiratory distress ,Pruritus within 24 hours after operation. Do you have hallucination or nightmare? : yes no Nausea vomiting : - Severity of nausea 4 scale : 0 = No 1. =minimal nausea and vomiting don't need medication 2. = nausea and vomiting participant was improved when received medication 3= nausea and vomiting participant wasn't improved when received medication Pruritus score 0= no 1= minimal 2= severe and need medication respiratory distress : sedation scale 0 = awake 1. minimal sedation : response to verbal conversation 2. moderated sedation : sleeping but easy to response to verbal conversation 3. deep sedation : difficult to response to

    Time frame: post operative time within 24 hours

07

Study locations

1 of 1 sites recruiting
  • Chomthong hospital
    Chiangmai, 50160, Thailand
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2024 (actual). Primary completion is estimated for Dec 2025, 23 months after the start.

Of 88 non-industry phase 4 interventional studies under Osteoarthritis, Knee, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 32. This study's planned 23 months is above that.

Counting every sponsor, half of 97 studies reached it within 19 months; a quarter within 10 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 2, 2024
First posted
Feb 20, 2024
StartActual
Jan 22, 2024
Primary completionEst.
Dec 31, 2025
CompletionEst.
Dec 31, 2025
Last update
Mar 12, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 12, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06267638
Lead sponsor
Ministry of Health, Thailand
Responsible party
Numphung Sukantarat (Anesthsiologist of Chomthong hospital, Chiangmai, Ministry of Health, Thailand) — Principal investigator
First posted
Feb 20, 2024
Start date
Jan 22, 2024
Primary completion
Dec 31, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Mar 12, 2024

Study contacts

Kanokwan Uthaiwan
Contact
manarw1@hotmail.com
66836999444

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Ketamine

Start the discussion